Tag: health canada

May 15, 2019

MediPharm Labs Signs Committed Term Sheet for $20 Million Debt Facility With Schedule 1 Bank

MediPharm Labs Corp. (TSXV:LABS, OTCQX:MEDIF, FSE:MLZ) (“MediPharm Labs”) a leader in specialized, research-driven cannabis extraction and cannabinoid isolation, is pleased to...
May 15, 2019

Lexaria’s DehydraTECHTM Formulation Delivers 475% More CBD to Bloodstream after 15 Minutes than Conventional Industry Formulations

Lexaria Bioscience Corp. (CSE:LXX, OTCQX:LXRP)  (the "Company" or "Lexaria"), a drug delivery platform innovator, has proven in animal testing that...
May 14, 2019

Cronos Group and MediPharm Labs Enter $30 Million Multi-Year Private Label Cannabis Concentrate Supply Agreement with Potential to Increase to $60 Million

MediPharm Labs Corp. (TSXV:LABS, OTCQX:MEDIF, FSE:MLZ) (“MediPharm Labs”) a leader in specialized, research-driven cannabis extraction and cannabinoid isolation, is pleased to announce...
May 10, 2019

MediPharm Labs Announces Q1 2019 Revenue of $22 Million and Adjusted EBITDA of $4.3 Million

MediPharm Labs Corp. (TSXV:LABS, OTCQX:MEDIF, FSE:MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation,...
May 8, 2019

Health Canada Raises Bar for Cannabis License Applicants

Health Canada has announced new standards that make it a requirement for applicants to have an approved facility from the...
May 8, 2019

MediPharm Labs Sets Date to Release First Quarter 2019 Financial Results

MediPharm Labs Corp. (TSXV:LABS, OTCQX:MEDIF, FSE:MLZ) (“MediPharm Labs” or the “Company”) is pleased to announce it will release its first...
May 7, 2019

Lexaria Bioscience Announces CBD-Beverage Formulation License Agreement with Nevada-Based Company

Lexaria Bioscience Corp. (CSE:LXX, OCTQX:LXRP) (the "Company" or "Lexaria"), a drug delivery platform innovator, announces that it has entered a...